Back to Newsroom
Back to Newsroom

Intercept Pharmaceuticals Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm

Wednesday, 24 May 2023 09:35 AM

Block & Leviton LLP

BOSTON, MA / ACCESSWIRE / May 24, 2023 / Block & Leviton is investigating Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) for potential securities law violations. Investors who have lost money in their Intercept Pharmaceuticals investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://www.blockleviton.com/cases/icpt.

What is this all about?

Before the market opened on May 17, 2023, the U.S. Food and Drug Administration (FDA) released briefing documents for an upcoming Gastrointestinal Drugs Advisory Committee meeting scheduled for May 19, 2023 to review Intercept Pharmaceuticals' liver disease candidate, Obeticholic Acid (OCA).

The briefing documents include concerns by FDA reviewers about the drug's risk-benefit profile, with the FDA noting, "Trial results for obeticholic acid indicate it causes multiple off-target effects that require multiple risk mitigation strategies with low likelihood of effectiveness."

Shares of Intercept Pharmaceuticals stock were down more than 20% in premarket trading and dropped more than 25% in intraday trading once the market opened on May 17, 2023.

Who is eligible?

Anyone who purchased Intercept Pharmaceuticals, Inc. stock and has lost money may be eligible, whether or not they have sold their investment. Investors should contact Block & Leviton to learn more.

What is Block & Leviton doing?

Block & Leviton is investigating whether the Company committed securities law violations and may file an action to attempt to recover losses on behalf of investors who have lost money.

What should you do next?

If you've lost money on your investment, you should contact Block & Leviton to learn more via our case website, by email at [email protected], or by phone at (617) 398-5600.

Why should you contact Block & Leviton?

Many law firms have issued releases about this matter; most of those firms do not actually litigate securities class actions. Block & Leviton is a law firm that actually litigates cases. We are dedicated to obtaining significant recoveries on behalf of defrauded investors through active litigation in the federal courts across the country. Many of the nation's top institutional investors hire us to represent their interests. You can learn more about us at our website, www.blockleviton.com, or call (617) 398-5600 or email [email protected] with any questions.

This notice may constitute attorney advertising.

CONTACT:

BLOCK & LEVITON LLP
260 Franklin St., Suite 1860
Boston, MA 02110
Phone: (617) 398-5600
Email: [email protected]
www.blockleviton.com

SOURCE: Block & Leviton LLP

Topic:
Class Action
Back to newsroom
Back to Newsroom
Share by: